Association between resistin levels and all-cause and cardiovascular mortality: A new study and a systematic review and meta-analysis

Andrea Fontana, Sara Spadaro, Massimiliano Copetti, Belinda Spoto, Lucia Salvemini, Patrizia Pizzini, Lucia Frittitta, Francesca Mallamaci, Fabio Pellegrini, Vincenzo Trischitta, Claudia Menzaghi

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Context Studies concerning the association between circulating resistin and mortality risk have reported, so far, conflicting results. Objective To investigate the association between resistin and both all-cause and cardiovascular (CV) mortality risk by 1) analyzing data from the Gargano Heart Study (GHS) prospective design (n=359 patients; 81 and 58 all-cause and CV deaths, respectively); 2) performing metaanalyses of all published studies addressing the above mentioned associations. Data Source and Study Selection MEDLINE and Web of Science search of studies reporting hazard ratios (HR) of circulating resistin for all-cause or CV mortality. Data Extraction Performed independently by two investigators, using a standardized data extraction sheet. Data Synthesis In GHS, adjusted HRs per one standard deviation (SD) increment in resistin concentration were 1.28 (95% CI: 1.07-1.54) and 1.32 (95% CI: 1.06-1.64) for all-cause and CV mortality, respectively. The meta-analyses included 7 studies (n=4016; 961 events) for all-cause mortality and 6 studies (n=4,187: 412 events) for CV mortality. Pooled HRs per one SD increment in resistin levels were 1.21 (95% CI: 1.03-1.42, Q-test p for heterogeneity

Original languageEnglish
Article numbere0120419
JournalPLoS One
Volume10
Issue number3
DOIs
Publication statusPublished - Mar 20 2015

Fingerprint

resistin
Resistin
systematic review
meta-analysis
Meta-Analysis
Mortality
Association reactions
heart
Information Storage and Retrieval
prospective studies
Hazards
MEDLINE
Cause of Death
Research Personnel
Prospective Studies
death
synthesis

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Association between resistin levels and all-cause and cardiovascular mortality : A new study and a systematic review and meta-analysis. / Fontana, Andrea; Spadaro, Sara; Copetti, Massimiliano; Spoto, Belinda; Salvemini, Lucia; Pizzini, Patrizia; Frittitta, Lucia; Mallamaci, Francesca; Pellegrini, Fabio; Trischitta, Vincenzo; Menzaghi, Claudia.

In: PLoS One, Vol. 10, No. 3, e0120419, 20.03.2015.

Research output: Contribution to journalArticle

Fontana, Andrea ; Spadaro, Sara ; Copetti, Massimiliano ; Spoto, Belinda ; Salvemini, Lucia ; Pizzini, Patrizia ; Frittitta, Lucia ; Mallamaci, Francesca ; Pellegrini, Fabio ; Trischitta, Vincenzo ; Menzaghi, Claudia. / Association between resistin levels and all-cause and cardiovascular mortality : A new study and a systematic review and meta-analysis. In: PLoS One. 2015 ; Vol. 10, No. 3.
@article{02cfd09ca5b04920a2abea76a99b67ec,
title = "Association between resistin levels and all-cause and cardiovascular mortality: A new study and a systematic review and meta-analysis",
abstract = "Context Studies concerning the association between circulating resistin and mortality risk have reported, so far, conflicting results. Objective To investigate the association between resistin and both all-cause and cardiovascular (CV) mortality risk by 1) analyzing data from the Gargano Heart Study (GHS) prospective design (n=359 patients; 81 and 58 all-cause and CV deaths, respectively); 2) performing metaanalyses of all published studies addressing the above mentioned associations. Data Source and Study Selection MEDLINE and Web of Science search of studies reporting hazard ratios (HR) of circulating resistin for all-cause or CV mortality. Data Extraction Performed independently by two investigators, using a standardized data extraction sheet. Data Synthesis In GHS, adjusted HRs per one standard deviation (SD) increment in resistin concentration were 1.28 (95{\%} CI: 1.07-1.54) and 1.32 (95{\%} CI: 1.06-1.64) for all-cause and CV mortality, respectively. The meta-analyses included 7 studies (n=4016; 961 events) for all-cause mortality and 6 studies (n=4,187: 412 events) for CV mortality. Pooled HRs per one SD increment in resistin levels were 1.21 (95{\%} CI: 1.03-1.42, Q-test p for heterogeneity",
author = "Andrea Fontana and Sara Spadaro and Massimiliano Copetti and Belinda Spoto and Lucia Salvemini and Patrizia Pizzini and Lucia Frittitta and Francesca Mallamaci and Fabio Pellegrini and Vincenzo Trischitta and Claudia Menzaghi",
year = "2015",
month = "3",
day = "20",
doi = "10.1371/journal.pone.0120419",
language = "English",
volume = "10",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "3",

}

TY - JOUR

T1 - Association between resistin levels and all-cause and cardiovascular mortality

T2 - A new study and a systematic review and meta-analysis

AU - Fontana, Andrea

AU - Spadaro, Sara

AU - Copetti, Massimiliano

AU - Spoto, Belinda

AU - Salvemini, Lucia

AU - Pizzini, Patrizia

AU - Frittitta, Lucia

AU - Mallamaci, Francesca

AU - Pellegrini, Fabio

AU - Trischitta, Vincenzo

AU - Menzaghi, Claudia

PY - 2015/3/20

Y1 - 2015/3/20

N2 - Context Studies concerning the association between circulating resistin and mortality risk have reported, so far, conflicting results. Objective To investigate the association between resistin and both all-cause and cardiovascular (CV) mortality risk by 1) analyzing data from the Gargano Heart Study (GHS) prospective design (n=359 patients; 81 and 58 all-cause and CV deaths, respectively); 2) performing metaanalyses of all published studies addressing the above mentioned associations. Data Source and Study Selection MEDLINE and Web of Science search of studies reporting hazard ratios (HR) of circulating resistin for all-cause or CV mortality. Data Extraction Performed independently by two investigators, using a standardized data extraction sheet. Data Synthesis In GHS, adjusted HRs per one standard deviation (SD) increment in resistin concentration were 1.28 (95% CI: 1.07-1.54) and 1.32 (95% CI: 1.06-1.64) for all-cause and CV mortality, respectively. The meta-analyses included 7 studies (n=4016; 961 events) for all-cause mortality and 6 studies (n=4,187: 412 events) for CV mortality. Pooled HRs per one SD increment in resistin levels were 1.21 (95% CI: 1.03-1.42, Q-test p for heterogeneity

AB - Context Studies concerning the association between circulating resistin and mortality risk have reported, so far, conflicting results. Objective To investigate the association between resistin and both all-cause and cardiovascular (CV) mortality risk by 1) analyzing data from the Gargano Heart Study (GHS) prospective design (n=359 patients; 81 and 58 all-cause and CV deaths, respectively); 2) performing metaanalyses of all published studies addressing the above mentioned associations. Data Source and Study Selection MEDLINE and Web of Science search of studies reporting hazard ratios (HR) of circulating resistin for all-cause or CV mortality. Data Extraction Performed independently by two investigators, using a standardized data extraction sheet. Data Synthesis In GHS, adjusted HRs per one standard deviation (SD) increment in resistin concentration were 1.28 (95% CI: 1.07-1.54) and 1.32 (95% CI: 1.06-1.64) for all-cause and CV mortality, respectively. The meta-analyses included 7 studies (n=4016; 961 events) for all-cause mortality and 6 studies (n=4,187: 412 events) for CV mortality. Pooled HRs per one SD increment in resistin levels were 1.21 (95% CI: 1.03-1.42, Q-test p for heterogeneity

UR - http://www.scopus.com/inward/record.url?scp=84925455240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925455240&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0120419

DO - 10.1371/journal.pone.0120419

M3 - Article

AN - SCOPUS:84925455240

VL - 10

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 3

M1 - e0120419

ER -